SIGA TECHNOLOGIES, INC. (OTCMKTS:SIGA) Files An 8-K Other Events
Item 8.01
|
Other Events.
|
Technologies, Inc. (the Company) filed a voluntary petition for
relief under chapter 11 of the United States Bankruptcy Code in
the United States Bankruptcy Court for the Southern District of
New York (the Bankruptcy Court), Case No. 14-12623 (the Chapter
11 Case).
Confirmation Order) confirming the Companys Plan of
Reorganization (the Plan). The Plan became effective on April 12,
2016, and the Confirmation Order, including the Plan, was
attached to the Companys Form 8-K filed on April 14, 2016.
Decree closing the Chapter 11 Case (the Final Decree). The Final
Decree is attached hereto as Exhibit 99.1 and incorporated herein
by reference.
| Item 9.01. |
Financial Statements and Exhibits.
|
| (c) |
Exhibits
|
|
Exhibit No.
|
Description
|
|
|
99.1
|
Final Decree Closing Chapter 11 Case of SIGA
Technologies, Inc., entered on December 22, 2016 in the United States Bankruptcy Court for the Southern District of New York. |
About SIGA TECHNOLOGIES, INC. (OTCMKTS:SIGA)
SIGA Technologies, Inc. (SIGA) is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company’s lead product is Tecovirimat, also known as ST-246, an orally administered antiviral drug that targets orthopoxviruses. Tecovirimat is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield). Tecovirimat is not approved by the United States Food and Drug Administration (FDA) as a treatment of smallpox or any other indication. Tecovirimat has Orphan Drug designation for both the treatment and prevention of smallpox, and the treatment of orthopoxvirus infections (vaccinia, variola, monkeypox and cowpox). The Company uses contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture Tecovirimat. The Company also has a lead pre-clinical drug candidate with activity against approximately four serotypes of the dengue virus. SIGA TECHNOLOGIES, INC. (OTCMKTS:SIGA) Recent Trading Information
SIGA TECHNOLOGIES, INC. (OTCMKTS:SIGA) closed its last trading session up +0.05 at 2.85 with shares trading hands.
